成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

返回ChemicalBook首頁>CAS數(shù)據(jù)庫列表>63676-22-2

63676-22-2

中文名稱 2-(4-羥基苯基)苯并[B]噻吩-6-醇
英文名稱 2-(4-Hydroxyphenyl)benzo[b]thiophene-6-ol
CAS 63676-22-2
分子式 C14H10O2S
分子量 242.293
MOL 文件 63676-22-2.mol
更新日期 2024/10/28 17:06:24
63676-22-2 結(jié)構(gòu)式 63676-22-2 結(jié)構(gòu)式

基本信息

中文別名
雷洛昔芬雜質(zhì)8
雷洛昔芬雜質(zhì)4
2-(4-羥基苯基)苯并[B]噻吩-6-醇
2-(4-羥苯基)-苯并[B]噻吩-6-醇
2-(4-羥苯基)苯并[B]噻吩-6-醇
英文別名
Raloxifene Impurity 4
Raloxifene InterMediate
Estrogen receptor modulator 1
BTC (Estrogen receptor modulator 1)
2-(4-Hydroxyphenyl)benzothiophene-6-ol
2-(4-Hydroxyphenyl)benzo[b]thiophen-6-ol
2-(4-hydroxyphenyl)-1-benzothiophen-6-ol
2-(4-hydroxyphenyl)-1-benzothiophene-6-ol
2-(4-Hydroxyphenyl)benzo[b]thiophene-6-ol
Benzo[b]thiophene-6-ol, 2-(4-hydroxyphenyl)-
所屬類別
醫(yī)藥中間體:噻吩類化合物

物理化學(xué)性質(zhì)

熔點(diǎn)295 °C(dec.)
沸點(diǎn)477.0±30.0 °C(Predicted)
密度1.383
儲存條件Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
溶解度可溶于DMSO(少許)、甲醇(少許)
酸度系數(shù)(pKa)9.32±0.15(Predicted)
形態(tài)固體
顏色淺灰色

安全數(shù)據(jù)

危險性符號(GHS)GHS hazard pictograms
GHS07
警示詞警告
危險性描述H413
防范說明P501-P273
海關(guān)編碼2934.99.4400

常見問題列表

生物活性
Estrogen receptor modulator 1 (compound 18) 是一種口服活性的選擇性 estrogen receptor 調(diào)節(jié)劑(SERM),pIC50值為0.46。Estrogen receptor modulator 1具有潛在的抗腫瘤活性。
靶點(diǎn)
TargetValue
ER
(Cell-free assay)
0.46(pIC50)
體外研究

Estrogen receptor modulator 1 (compound 18) (100 nM; 10 days) inhibits T47D:A18/PKCα and T47D:A18-TAM1 colony formation.
Estrogen receptor modulator 1 (100 nM; 9 days) significantly inhibits the growth of MCF-7:5C cell, and induces apoptosis in these cells 6 days.

Cell Proliferation Assay

Cell Line: T47D:A18/PKCα and T47D:A18-TAM1 cells
Concentration: 100 nM
Incubation Time: 10 days
Result: Inhibit T47D:A18/PKCα and T47D:A18-TAM1 colony formation.

Cell Viability Assay

Cell Line: MCF-7:5C cells
Concentration: 100 nM
Incubation Time: 9 days
Result: Significantly inhibited the growth of MCF-7:5C cells.
體內(nèi)研究

Estrogen receptor modulator 1 (1.5 mg/animal; p.o. ; daily for 2 weeks) results in regression of T47D:A18/PKCα tumors.

Animal Model: 4-6 week old athymic mice (Harlan-Sprague-Dawley)
Dosage: 1.5 mg/animal
Administration: p.o. ; daily for 2 weeks
Result: Significantly reduced tumor volume.
"63676-22-2" 相關(guān)產(chǎn)品信息
1391054-73-1 938140-30-8 195454-31-0 1159977-58-8 84449-85-4 174264-50-7 414861-41-9 1188263-47-9 182507-22-8 618902-12-8 937666-17-6 1279033-52-1 1190867-20-9 767286-87-3 225648-21-5 175460-94-3 2008-75-5 84449-65-0